Recent posts and comments

• Ironwood Goes Public, Glasshouse and BG Medicine Aim to Do the Same, Vivox Collects $6.8M, & More Boston-Area Deals News

  For the first time in as long as I can remember, IPOs dominated the New England tech and life sciences deals news this week.

  —Glasshouse Technologies, an IT consulting firm in... Read more »

• Alnara Adds $35M, Harvest Power Teams Up with Waste Management, & More Boston-Area Deals News

  We spent some time this week looking at the data on last year’s venture deals, big and small, while New England’s tech and life sciences companies announced some of the first... Read more »

• Introducing Erin Kutz, Belatedly

  You know a new hire is a good fit when by the end of her first day you’ve already forgotten that she’s new. And that’s just what happened when our new... Read more »

• Vertex CEO on Building a Blockbuster, Genzyme Investor on Fixing Up the Firm, Cubist CEO on Pipeline and Patent Challenges, & More Boston-Area Life Sciences News

  If in-depth interviews with some of the heaviest hitters in the New England life sciences industry are your cup of tea, this was the week for you.

  —Ryan had a fascinating... Read more »

• Time Inc. Scoops Up StyleFeeder, Ironwood Sets Sights on Potential $266.7 M IPO, FloDesign Reveals $34.5M Financing, & More Boston-Area Deals News

  It was a short week, but the list of deals that New England’s tech and life sciences firms inked in that span is a long one. Let’s dive in:

  —StyleFeeder, the... Read more »

• IkaSystems Raises $120M, New CEOs of Qteros, Bind, and Quanterix Dish the Dirt, & More Boston-Area Life Sciences News

  This week Ryan and Luke had several great interviews with some of the newest CEOs in New England life sciences. Those and the rest of the week’s biotech, devices, and health... Read more »

• MLK Day

  Posting will be light today as Xconomy’s offices are closed in observation of the Martin Luther King, Jr. Day of Service.

  For those of you looking for a way to... Read more »

• A123Systems Invests in Fisker, Virtify Finds $15M, ATG Acquires InstantService, & More Boston-Area Deals News

  Dealmaking was steady across the tech and life sciences industries in New England this week.

  —Enterprise software firm Progress Software (NASDAQ: PRGS) of Bedford, MA, acquired Santa Clara, CA-based... Read more »

• Genzyme Reaches Agreement with Activist Investor, Charles River Closes Shrewsbury Lab, Lycera Comes to Cambridge, & More Boston-Area Life Sciences News

  It was another crazy-busy week for New England’s life sciences firms, many of which closed small-to-medium sized venture financings. I’ll talk about those as part of Friday’s deals roundup, but in... Read more »

• Quattro Scooped Up By Apple, Medtronic Invests in GI Dynamics, EMC Acquires Archer, & More Boston-Area Deals News

  New England’s tech and life sciences companies hit the ground running in the new year, inking a host of deals this week.

  —Data storage giant EMC of Hopkinton, MA, made a... Read more »

• Mullen to Relinquish Biogen Idec Reins, Joule to Test Ethanol Tech, Dicerna to Team with Kyowa Hakko Kirin, & More Boston-Area Life Sciences News

  I’ve got a couple weeks’ worth of New England life sciences news to catch you up on, so let’s dive in.

  —Shares of Watertown, MA-based pSivida (NASDAQ: PSDV) jumped more... Read more »

• Enjoy the holidays, and watch this space…

  The boys and I will be taking some much needed time off for the next week and a half, so posting will be light in the main blog and News Xpress... Read more »

• Biogen Drops Facet Bid, Aveo Reveals IPO Ambitions, Pfizer Partners with Adimab, & More Boston-Area Life Sciences News

  New England’s drug developers and device makers are squeezing in a few more partnerships, acquisitions, financings, and strategic moves before the year’s end.

  —Acceleron Pharma, the Cambridge, MA-based biotech that’s building... Read more »

• Aveo Aims for $86M Debut, Exagrid Snags $16M, PatientKeeper Adds $13M, & More Boston-Area Deals News

  In honor of the eighth day of Hanukah, here are the top eight deals of the last week.

  —Lexington, MA-based Cubist Pharmaceuticals (NASDAQ:CBST) inked a deal to acquire... Read more »

• Biogen Idec Board in Flux, Cubist Acquires Calixa, ImmunoGen Drug Passes Clinical Test, & More Boston-Area Life Sciences News

  Gadzooks, was this a busy news week for the biotech, devices, and healthcare IT sectors in New England. Here’s the lightning round version:

  —Luke examined Cambridge, MA-based Biogen Idec (NASDAQ: BIIB... Read more »

• 5AM Gathers $200M Fund, Advanced Cell Technology Advances with $2.8 Million, Gloucester Picked up for $640M, & More Boston-Area Deals News

  Lots of deals to report this week from New England tech and life sciences companies.

  —Gloucester Pharmaceuticals of Cambridge, MA, agreed to an acquisition by Summit, NJ-based Celgene (NASDAQ: CELG).... Read more »

• Facet Rejects Biogen’s Latest Offer

  The board of Redwood City, CA-based Facet Biotech (NASDAQ:FACT) unanimously recommended that shareholders reject the latest tender offer from Cambridge, MA-based Biogen Idec (NASDAQ:BIIB), saying that the... Read more »

• A Graceful Exit for Gloucester, Pink Slips at Sermo, A Half a Billion Bucks for Vertex, & More Boston-Area Life Sciences News

  New England’s life sciences firms and their investors seemed to be exchanging some early holiday gifts this week.

  —Vertex (NASDAQ: VRTX) completed the latest in a string of large... Read more »

• $443 million for Vertex, $25.5M for Forma, $8M for Contour Semiconductor, & More Boston-Area Deals News

  The dollar amounts ranged from the modest (FitnessKeeper) to the mammoth (Vertex) for New England tech and life sciences deals this week.

  —Boston’s FitnessKeeper, maker of the RunKeeper iPhone application, raised... Read more »

• Forma Gets a $25.5M Fix, Novartis Bids Idera Adieu, Alnylam CEO Talks Strategy, & More Boston-Area Life Sciences News

  Somewhere between the turkey prep and the post-pie catatonia, folks at New England’s life sciences companies managed to make some news.

  —Idera Pharmaceuticals (NASDAQ:IDRA), a developer of DNA- and... Read more »